Is systolic heart failure characterized by an ejection fraction of less than 40%, pulmonary congestion, cardiomegaly on chest x-ray, a decreased left ventricle, and an S3 gallop?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Characteristics of Systolic Heart Failure

Yes, systolic heart failure is characterized by an ejection fraction of less than 40%, pulmonary congestion with cardiomegaly on chest x-ray, decreased left ventricular function, and often an S3 gallop. 1

Diagnostic Criteria for Systolic Heart Failure

Systolic heart failure has specific diagnostic features that distinguish it from other forms of heart failure:

Ejection Fraction

  • Ejection fraction less than 40% is the primary defining characteristic of systolic heart failure 1
  • This contrasts with heart failure with preserved ejection fraction (HFpEF), which is defined by an LVEF ≥50% 2

Imaging Findings

  • Chest X-ray findings:

    • Pulmonary congestion (venous or alveolar congestion, interstitial or pulmonary edema)
    • Pleural effusion
    • Cardiomegaly 1
    • Cephalization of venous flow 1
  • Echocardiographic findings:

    • Reduced LV ejection fraction (<40%)
    • Reduced LV fractional shortening (<25%)
    • Increased LV end-diastolic size (diameter ≥60 mm, >32 mm/m², volume >97 mL/m²)
    • Increased LV end-systolic size (diameter >45 mm/>25 mm/m², volume >43 mL/m²) 1
    • Regional wall motion abnormalities (especially in ischemic heart failure) 1

Physical Examination Findings

  • S3 gallop (third heart sound) - a hallmark finding in systolic heart failure 1
  • Other common findings include:
    • Dyspnea with exertion or recumbency
    • Dependent edema
    • Rapid fatigue
    • Cough
    • Early satiety 1

Pathophysiology

Systolic heart failure represents impaired emptying of the left ventricle, manifested as:

  • Decreased contractile function
  • Ventricular dilation
  • Reduced cardiac output 3
  • Progressive pump failure, which is one of the most frequent causes of death 1

Distinguishing from Other Forms of Heart Failure

It's important to distinguish systolic heart failure from:

  1. Heart Failure with Preserved Ejection Fraction (HFpEF):

    • HFpEF has EF ≥50% 2
    • Often presents with similar symptoms but different pathophysiology 4
    • More common in elderly women with systolic hypertension 4
  2. Heart Failure with Mildly Reduced Ejection Fraction:

    • EF between 40-49% (falls between systolic heart failure and HFpEF)

Clinical Implications

The diagnosis of systolic heart failure has important treatment implications:

  • Patients with systolic heart failure benefit from neurohormonal modulation therapies 5
  • Accurate diagnosis guides therapy selection and prognosis assessment
  • The presence of an S3 gallop and cardiomegaly on chest x-ray are important clinical markers that help confirm the diagnosis when combined with reduced ejection fraction 1

Common Pitfalls

  • Relying solely on ejection fraction without considering other clinical and imaging findings
  • Failing to recognize that systolic dysfunction is the most common cause of diastolic dysfunction and pulmonary congestion 3
  • Not considering other causes of cardiomegaly and pulmonary congestion such as valvular disease

By accurately identifying these characteristic features of systolic heart failure, clinicians can make appropriate treatment decisions that impact morbidity and mortality outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Heart Failure with Preserved Ejection Fraction (HFpEF) Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Congestive heart failure: systolic and diastolic function.

Journal of cardiothoracic and vascular anesthesia, 1993

Research

Heart failure with a normal left ventricular ejection fraction: diastolic heart failure.

Transactions of the American Clinical and Climatological Association, 2008

Research

Systolic heart failure: chronic and acute syndromes.

Critical care medicine, 2008

Related Questions

What is the prognosis and management for a patient with a severely reduced ejection fraction (EF) of 15%?
What is the best management approach for an 87-year-old patient with acute on chronic combined systolic and diastolic heart failure and severe hyperkalemia (Basic Metabolic Panel (BMP) result of 4168 likely indicating hyperkalemia)?
How to manage a 93-year-old female with elevated HbA1C, hyperglycemia, HFpEF (Heart Failure with preserved Ejection Fraction), AF (Atrial Fibrillation), on metformin (metformin hydrochloride) 500 mg bid, and with a PMP (Permanent Pacemaker) VVIR (Ventricular Pacing, Ventricular Sensing, Inhibited Response) setting?
What is the best management approach for a 93-year-old female with Heart Failure with preserved Ejection Fraction (HFpEF), Atrial Fibrillation (AF), and a Permanent Pacemaker (PMP) with VVIR setting, who has had an episode of hyperglycemia while on metformin (metformin hydrochloride) with otherwise satisfactory glycemic control?
What is the appropriate management for an 80-year-old patient with shortness of breath and fatigue, diagnosed with grade II diastolic dysfunction and mild pulmonary hypertension?
What is the recommended initial treatment for pediatric patients with nephrotic syndrome?
What is the typical time to onset of action for Cymbalta (duloxetine)?
What is the recommended taper schedule for a patient taking 0.25mg of Xanax (alprazolam)?
What are the indications, dosing, and potential side effects of Duloxetine (Cymbalta)?
What are the side effects of Mounjaro (tirzepatide)?
What is the treatment for bacterial vaginosis (BV) in a child?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.